Get updates delivered to you daily. Free and customizable.
New York Post
Ozempic to treat arthritis? Why doctors say obesity drugs could cure a host of chronic illnesses
By Reda Wigle,
9 days ago
Can Ozempic help cure arthritis? Some doctors say so.
Many overweight patients struggle with chronic conditions like high blood pressure, fatty liver, rheumatoid arthritis, and sleep apnea.
Now, some doctors are suggesting an “obesity first” approach to treating these issues.
The idea is to treat obesity with medications approved for that use and, as weight drops, other chronic diseases will also improve or go away altogether.
By prescribing a drug such as Wegovy from Novo Nordisk or Zepbound from Eli Lilly, in addition to diet and exercise, doctors are confident they can treat obesity and improve related conditions with a single medication.
Dr. Caroline M. Apovian, an obesity medicine specialist at Brigham and Women’s Hospital in Boston, tells The New York Times , “You get the weight loss, and you’ve treated the high blood pressure, the fatty liver, the diabetes, the high cholesterol, the high triglycerides.”
Some healthcare professionals believe obesity drugs may treat a variety of conditions including high blood pressure. hedgehog94 – stock.adobe.com
Dr. Apovian reports that patients who follow this protocol are delighted with the streamlining of their bodies and their medications. As a bonus, patients often keep taking their obesity drugs, a consistency that’s less common for prescriptions like statins.
Still, some docs are skeptical of the “obesity first” initiative.
Some doctors are skeptical of the ‘obesity first’ initiative. millaf – stock.adobe.com
Detractors note that patients with obesity can be easily turned off by a doctor who mentions their weight. In addition, obesity drugs are expensive, and while they may provide unexpected benefits, more studies are needed to verify their effectiveness.
This contingent points out that the prudent approach is to use well-tested drugs, available in affordable generic form, to treat conditions that accompany obesity.
Wegovy was recently approved by the FDA to treat heart related conditions. Getty Images
Both the makers of these medications and skeptical physicians are calling for rigorous studies to establish what effect obesity medications will have in treating multiple conditions.
Dr. Daniel Drucker, an obesity researcher at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto, tells The Times that many of these positive effects may stem from the drugs’ ability to reduce inflammation.
Dr. Drucker mentions patients whose crippling rheumatoid arthritis has all but vanished after taking Zepbound for obesity.
Obesity drugs may benefit the body by decreasing inflammation. bnenin – stock.adobe.com
In a clinical trial , Wegovy use was linked to improved ability to exercise in people with diabetes and heart failure.
Recent studies have shown drugs like Wegovy, and Ozempic may be beneficial in both preventing and treating alcohol use disorders, and in March, Wegovy was approved by the FDA to reduce the risk of stroke, heart attacks, and other serious cardiovascular problems in patients who are overweight or who have obesity.
For the latest in lifestyle, top headlines, breaking news and more, visit nypost.com/lifestyle/
Get updates delivered to you daily. Free and customizable.
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. We strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation. Join us in shaping the news narrative together.
Comments / 0